Guidance & Assistance
for Stakeholders in Flanders
on European funding programmes

Latest news

  • EIC

EIC Work Programme 2027 adopted

The 2027 work programme opens funding opportunities worth over €1.8 billion for strategic technologies and scaling up companies. The EIC work programme 2027 details the funding in six main schemes: EIC Pathfinder EIC Transition Advanced Innovation Challenges EIC Accelerator The EIC Strategic Technologies for Europe Platform (STEP) Scale Up EIC...

Read more
  • Digital, Industry & Space
  • Climate, Energy, Mobility
  • Agro-Food, Environment

The European Commission and European Space Agency launch a joint website showcasing collaborative research on our changing planet

The European Commission and ESA have launched a new website for the Earth System Science Initiative (ESSI). The site brings together collaborative research on climate change, biodiversity loss, ocean health and other environmental challenges. It presents participating projects, scientific alliances and emerging results from EU- and ESA-supported research.

Read more
  • Defence
  • DIRS

Start2Def 2026 call open

The Start2Def 2026 selection process opened on 4 November 2026. Belgian startups and small SMEs can submit proof-of-concept ideas for one of two defence-related challenges.

Read more

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Handy tools

Free tools to find your way in European funding.

Event calendar

  • ERC

Science communication training for ERC grantees

NOV
Mon
09

The ERC is inviting expressions of interest from current ERC grantees for a one-day science communication training taking place in Brussels. Interested ERC grantees are invited to complete the online expression of interest form. The deadline for applications is 24 August 2026 12 pm CEST. Notification of selected participants (approximately 40) is...

Read more
  • Enhancing EU R&I

VALLEYS info day first open call for applicants strand B & C

NOV
Mon
09

The project VALLEYS aims to strengthen knowledge valorisation in Europe by building a network of knowledge valorisation intermediaries connecting more than 150 organisations from over 25 countries, empowering organisations such as TTOs, incubators, science parks, clusters, and citizen engagement entities to adopt and scale the EU Guiding Principles...

Read more
  • Health
  • EIC

EIC VentureMatch Pitching on Health Biotech

NOV
Tue
10

EIC-backed health biotech companies ready to pitch their innovation to investors can Apply for the EIC VentureMatch Pitching on Health Biotech during BIO-Europe.The investor panel includes: NRW.BANK, LifeArc Ventures, DeepTech & Climate Fonds (DTCF), Apollo Health Ventures, Forbion, Bayern Kapital, M Ventures.Organised under the EIC...

Read more
  • Health

Transforming Health and Care Systems Annual Conference 2026

NOV
Tue
10

This one-day pre-conference is organised by the Transforming Health and Care Systems (THCS) Partnership as part of the European Public Health Conference programme. The conference will focus on how health and care systems can respond to climate, equity and innovation challenges.

Read more

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.